Tenbusch M, Schumacher S, Vogel E, Priller A, Held J, Steininger P, Beileke S, Irrgang P, Brockhoff R, Salmanton-García J, Tinnefeld K, Mijocevic H, Schober K, Bogdan C, Yazici S, Knolle P, Cornely OA, Überla K, Protzer U; DZIF-VACCELERATE-CoVaKo study team.
Lancet Infect Dis. 2021 Sep;21(9):1212-1213. doi: 10.1016/S1473-3099(21)00420-5. Epub 2021 Jul 29.
NO ABSTRACT
PMID:34332707 | PMC:PMC8321428 | DOI:10.1016/S1473-3099(21)00420-5
General-purpose virus-neutralizing engulfing shells with modular target-specificity
On 31 January 2025, the third and final project period of the VIROFIGHT project officially concluded, marking the successful completion of the project. We are pleased to share the final project summary, which highlights the key achievements and the broader impact of the research conducted over the course of the project.
VIROFIGHT has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899619.